Validation of functionalized transcription factors as a novel cell culture supplements
功能化转录因子作为新型细胞培养补充剂的验证
基本信息
- 批准号:508698-2017
- 负责人:
- 金额:$ 1.39万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Collaborative Research and Development Grants
- 财政年份:2019
- 资助国家:加拿大
- 起止时间:2019-01-01 至 2020-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The market for cell culture media and supplements is estimated to be $6 billion per year as reported by Global Industry Analysts Inc. The overall goal of this project is to validate novel protein therapeutics consisting of transcription factors functionalized with a novel intracellular protein delivery technology developed by iProgen Biotech for use as cell culture supplements. This project represents a continuation of a successful collaboration between Dr. Stephanie Willerth, a Canada Research Chair in Biomedical Engineering and Associate Professor of Biomedical Engineering at the University of Victoria, and the biotechnology company - iProgen Biotech. Our previous collaboration validated a novel protein therapeutic called IASCL1 for use as a cell culture supplement that promoted the differentiation of human induced pluripotent stem cells into neurons, which are cells found in the central nervous system. We also have promising preliminary data that IASCL can directly reprogram skin cells called fibroblasts into neuron-like cells. This project will further characterize ability of IASCL1 to reprogram fibroblasts into neurons as well as characterize the effects of other novel transcription factors, including ISOX2, IBRN2, IMYT1L, and INGN2, on the reprogramming process.
据全球工业分析公司报道,细胞培养基和补充剂的市场估计每年为60亿美元。该项目的总体目标是验证由iProgen Biotech开发的一种新型细胞内蛋白质传递技术功能化的转录因子组成的新型蛋白质疗法,用于细胞培养补充剂。该项目是加拿大生物医学工程研究主席、维多利亚大学生物医学工程副教授Stephanie Willerth博士与生物技术公司iProgen Biotech成功合作的延续。我们之前的合作验证了一种名为IASCL1的新型蛋白质疗法,该疗法可作为细胞培养补充物,促进人类诱导多能干细胞向神经元的分化,神经元是在中枢神经系统中发现的细胞。我们也有很有希望的初步数据,IASCL可以直接将称为成纤维细胞的皮肤细胞重编程为神经元样细胞。本项目将进一步表征IASCL1将成纤维细胞重编程为神经元的能力,以及其他新型转录因子(包括ISOX2、IBRN2、IMYT1L和INGN2)在重编程过程中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Willerth, Stephanie其他文献
Guggulsterone-releasing microspheres direct the differentiation of human induced pluripotent stem cells into neural phenotypes
- DOI:
10.1088/1748-605x/aaaa77 - 发表时间:
2018-05-01 - 期刊:
- 影响因子:4
- 作者:
Agbay, Andrew;De La Vega, Laura;Willerth, Stephanie - 通讯作者:
Willerth, Stephanie
Willerth, Stephanie的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Willerth, Stephanie', 18)}}的其他基金
Engineering neural tissue using pluripotent stem cells
使用多能干细胞改造神经组织
- 批准号:
RGPIN-2017-04044 - 财政年份:2022
- 资助金额:
$ 1.39万 - 项目类别:
Discovery Grants Program - Individual
Engineering neural tissue using pluripotent stem cells
使用多能干细胞改造神经组织
- 批准号:
RGPIN-2017-04044 - 财政年份:2021
- 资助金额:
$ 1.39万 - 项目类别:
Discovery Grants Program - Individual
Development of HeartPrint Bioink
HeartPrint Bioink 的开发
- 批准号:
571266-2022 - 财政年份:2021
- 资助金额:
$ 1.39万 - 项目类别:
Idea to Innovation
Engineering neural tissue using pluripotent stem cells
使用多能干细胞改造神经组织
- 批准号:
RGPIN-2017-04044 - 财政年份:2020
- 资助金额:
$ 1.39万 - 项目类别:
Discovery Grants Program - Individual
Engineering neural tissue using pluripotent stem cells
使用多能干细胞改造神经组织
- 批准号:
RGPIN-2017-04044 - 财政年份:2019
- 资助金额:
$ 1.39万 - 项目类别:
Discovery Grants Program - Individual
Facility for Real Time Imaging of 3D Bioprinted Neural Tissues
3D 生物打印神经组织实时成像设施
- 批准号:
RTI-2020-00147 - 财政年份:2019
- 资助金额:
$ 1.39万 - 项目类别:
Research Tools and Instruments
相似海外基金
Investigating Immune Responses to Neoantigen Cancer Vaccines using In Vivo Functionalized Lineage
使用体内功能化谱系研究对新抗原癌症疫苗的免疫反应
- 批准号:
10558688 - 财政年份:2022
- 资助金额:
$ 1.39万 - 项目类别:
Supplement to Model-aided Design and Integration of Functionalized Hybrid Nanomaterials for EnhancedBioremediation of PFASs Using Supercritical Fluid Chromatography/Mass Spectrometry
使用超临界流体色谱/质谱法增强 PFAS 生物修复功能化混合纳米材料的模型辅助设计和集成的补充
- 批准号:
10601888 - 财政年份:2022
- 资助金额:
$ 1.39万 - 项目类别:
Model-aided Design and Integration of Functionalized Hybrid Nanomaterials for Enhanced Bioremediation of Per-and Polyfluoroalkyl Substances (PFASs)
功能化杂化纳米材料的模型辅助设计和集成,用于增强全氟烷基物质和多氟烷基物质 (PFAS) 的生物修复
- 批准号:
10319174 - 财政年份:2021
- 资助金额:
$ 1.39万 - 项目类别:
Model-aided Design and Integration of Functionalized Hybrid Nanomaterials for Enhanced Bioremediation of Per-and Polyfluoroalkyl Substances (PFASs)
功能化杂化纳米材料的模型辅助设计和集成,用于增强全氟烷基物质和多氟烷基物质 (PFAS) 的生物修复
- 批准号:
10728494 - 财政年份:2021
- 资助金额:
$ 1.39万 - 项目类别:
Model-aided Design and Integration of Functionalized Hybrid Nanomaterials for Enhanced Bioremediation of Per-and Polyfluoroalkyl Substances (PFASs)
功能化杂化纳米材料的模型辅助设计和集成,用于增强全氟烷基物质和多氟烷基物质 (PFAS) 的生物修复
- 批准号:
10515650 - 财政年份:2021
- 资助金额:
$ 1.39万 - 项目类别:
Model-aided Design and Integration of Functionalized Hybrid Nanomaterials for Enhanced Bioremediation of Per-and Polyfluoroalkyl Substances (PFASs)
功能化杂化纳米材料的模型辅助设计和集成,用于增强全氟烷基物质和多氟烷基物质 (PFAS) 的生物修复
- 批准号:
10156782 - 财政年份:2021
- 资助金额:
$ 1.39万 - 项目类别:
Injectable Carbon Nanotube-Functionalized Hydrogel for miRNA Delivery
用于 miRNA 传递的可注射碳纳米管功能化水凝胶
- 批准号:
9977415 - 财政年份:2020
- 资助金额:
$ 1.39万 - 项目类别:
Injectable Carbon Nanotube-Functionalized Hydrogel for miRNA Delivery
用于 miRNA 传递的可注射碳纳米管功能化水凝胶
- 批准号:
10421055 - 财政年份:2020
- 资助金额:
$ 1.39万 - 项目类别:
Injectable Carbon Nanotube-Functionalized Hydrogel for miRNA Delivery
用于 miRNA 传递的可注射碳纳米管功能化水凝胶
- 批准号:
10175017 - 财政年份:2020
- 资助金额:
$ 1.39万 - 项目类别:
Injectable Carbon Nanotube-Functionalized Hydrogel for miRNA Delivery
用于 miRNA 传递的可注射碳纳米管功能化水凝胶
- 批准号:
10625847 - 财政年份:2020
- 资助金额:
$ 1.39万 - 项目类别: